Literature DB >> 19032574

Characterization of a functional polymorphism in the 3' UTR of SLC6A4 and its association with drinking intensity.

Chamindi Seneviratne1, Weihua Huang, Nassima Ait-Daoud, Ming D Li, Bankole A Johnson.   

Abstract

BACKGROUND: The propensity for severe drinking is hypothesized to be regulated by differential expression of serotonin transporter gene (SLC6A4) in the human brain. The SLC6A4 promoter region 5-HTTLPR has been examined previously as a candidate polymorphic variant associated with severe drinking. In this study, we investigated whether other SLC6A4 single nucleotide polymorphisms (SNPs) are associated with drinking intensity among treatment-seeking alcoholics and whether these polymorphic variants result in differential SLC6A4 expression levels.
METHODS: We analyzed associations of drinking intensity in 275 (78.5% male) treatment-seeking alcoholics of Caucasian and Hispanic origin, with 6 SLC6A4 polymorphisms. Next, to examine the functionality of the SNP that showed a significant association with drinking intensity, we transfected the 2 alleles of rs1042173 into HeLa cell cultures and measured serotonin transporter mRNA and protein expression levels by using qRT-PCR and western blotting techniques.
RESULTS: One of the 6 polymorphisms we examined, rs1042173 in the 3' untranslated region (3'-UTR) of SLC6A4, showed a significant association with drinking intensity. The G allele carriers for rs1042173 were associated with significantly lower drinking intensity (p = 0.0034) compared to T-allele homozygotes. In HeLa cell cultures, the cells transfected with G allele showed a significantly higher mRNA and protein levels than the T allele-transfected cells.
CONCLUSION: These findings suggest that the allelic variations of rs1042173 affect drinking intensity in alcoholics possibly by altering serotonin transporter expression levels. This provides additional support to the hypothesis that SLC6A4 polymorphisms play an important role in regulating propensity for severe drinking.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19032574      PMCID: PMC2657929          DOI: 10.1111/j.1530-0277.2008.00837.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  38 in total

1.  Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy.

Authors:  William Dundon; Kevin G Lynch; Helen M Pettinati; Craig Lipkin
Journal:  Alcohol Clin Exp Res       Date:  2004-07       Impact factor: 3.455

2.  Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

Authors:  J T Sullivan; K Sykora; J Schneiderman; C A Naranjo; E M Sellers
Journal:  Br J Addict       Date:  1989-11

Review 3.  Diverse actions of ovarian steroids in the serotonin neural system.

Authors:  Cynthia L Bethea; Nick Z Lu; Chrisana Gundlah; John M Streicher
Journal:  Front Neuroendocrinol       Date:  2002-01       Impact factor: 8.606

Review 4.  Gender differences in depression and antidepressant pharmacokinetics and adverse events.

Authors:  E J Frackiewicz; J J Sramek; N R Cutler
Journal:  Ann Pharmacother       Date:  2000-01       Impact factor: 3.154

5.  Multimarkerhaplotypes within the serotonin transporter gene suggest evidence of an association with bipolar disorder.

Authors:  L Mynett-Johnson; C Kealey; E Claffey; D Curtis; L Bouchier-Hayes; C Powell; P McKeon
Journal:  Am J Med Genet       Date:  2000-12-04

6.  Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype.

Authors:  N Ozaki; D Goldman; W H Kaye; K Plotnicov; B D Greenberg; J Lappalainen; G Rudnick; D L Murphy
Journal:  Mol Psychiatry       Date:  2003-11       Impact factor: 15.992

7.  Development of novel pharmacotherapies for the treatment of alcohol dependence: focus on antiepileptics.

Authors:  Bankole A Johnson; Robert M Swift; Nassima Ait-Daoud; Carlo C DiClemente; Martin A Javors; Robert J Malcolm
Journal:  Alcohol Clin Exp Res       Date:  2004-02       Impact factor: 3.455

8.  Functional variation in the 3' untranslated region of the serotonin transporter in human and rhesus macaque.

Authors:  E J Vallender; C M Priddy; S Hakim; H Yang; G-L Chen; G M Miller
Journal:  Genes Brain Behav       Date:  2008-04-28       Impact factor: 3.449

Review 9.  Serotonin uptake blockers and voluntary alcohol consumption. A review of recent studies.

Authors:  K Gill; Z Amit
Journal:  Recent Dev Alcohol       Date:  1989

10.  Solubilization of the platelet plasma membrane serotonin transporter in an active form.

Authors:  J Talvenheimo; G Rudnick
Journal:  J Biol Chem       Date:  1980-09-25       Impact factor: 5.157

View more
  24 in total

Review 1.  Pharmacogenetic approaches to the treatment of alcohol addiction.

Authors:  Markus Heilig; David Goldman; Wade Berrettini; Charles P O'Brien
Journal:  Nat Rev Neurosci       Date:  2011-10-20       Impact factor: 34.870

Review 2.  Pharmacotherapy of alcohol use disorders: seventy-five years of progress.

Authors:  Leah R Zindel; Henry R Kranzler
Journal:  J Stud Alcohol Drugs Suppl       Date:  2014

3.  Serotonin transporter and receptor genes significantly impact nicotine dependence through genetic interactions in both European American and African American smokers.

Authors:  Zhongli Yang; Chamindi Seneviratne; Shaolin Wang; Jennie Z Ma; Thomas J Payne; Jundong Wang; Ming D Li
Journal:  Drug Alcohol Depend       Date:  2013-01-04       Impact factor: 4.492

Review 4.  Monoamine transporters: vulnerable and vital doorkeepers.

Authors:  Zhicheng Lin; Juan J Canales; Thröstur Björgvinsson; Morgane Thomsen; Hong Qu; Qing-Rong Liu; Gonzalo E Torres; S Barak Caine
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

Review 5.  Serotonin gene variants are unlikely to play a significant role in the pathogenesis of the sudden infant death syndrome.

Authors:  David S Paterson
Journal:  Respir Physiol Neurobiol       Date:  2013-07-10       Impact factor: 1.931

6.  Association of a polyadenylation polymorphism in the serotonin transporter and panic disorder.

Authors:  Sandeep Gyawali; Ryan Subaran; Myrna M Weissman; Dylan Hershkowitz; Morgan C McKenna; Ardesheer Talati; Abby J Fyer; Priya Wickramaratne; Phillip B Adams; Susan E Hodge; Carl J Schmidt; Michael J Bannon; Charles E Glatt
Journal:  Biol Psychiatry       Date:  2009-12-06       Impact factor: 13.382

7.  Effects of Recent Stress and Variation in the Serotonin Transporter Polymorphism (5-HTTLPR) on Depressive Symptoms: A Repeated-Measures Study of Adults Age 50 and Older.

Authors:  Thalida E Arpawong; Jinkook Lee; Drystan F Phillips; Eileen M Crimmins; Morgan E Levine; Carol A Prescott
Journal:  Behav Genet       Date:  2015-09-02       Impact factor: 2.805

8.  Independent effects of 5' and 3' functional variants in the serotonin transporter gene on suicidal behavior in the context of childhood trauma.

Authors:  Mary-Anne Enoch; Colin A Hodgkinson; Elena Gorodetsky; David Goldman; Alec Roy
Journal:  J Psychiatr Res       Date:  2013-04-01       Impact factor: 4.791

9.  Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT(3) antagonist ondansetron.

Authors:  Bankole A Johnson; Chamindi Seneviratne; Xin-Qun Wang; Nassima Ait-Daoud; Ming D Li
Journal:  Am J Psychiatry       Date:  2013-09       Impact factor: 18.112

10.  Pharmacotherapies and personalized medicine for alcohol use disorder: a review.

Authors:  Falk W Lohoff
Journal:  Pharmacogenomics       Date:  2020-08-18       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.